Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T13:52:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, making the study record inaccessible. This indicates an access issue rather than new content on the page.
    Difference
    19%
    Check dated 2026-09-23T19:15:28.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0 on the page, indicating a new version of the page. This metadata change does not modify visible study details.
    Difference
    0.0%
    Check dated 2026-09-16T21:45:03.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A new publication citation was added to the study's Publications section, describing extramusculoskeletal manifestations in upadacitinib-treated patients with Psoriatic Arthritis or Axial Spondyloarthritis.
    Difference
    0.0%
    Check dated 2026-09-09T21:50:14.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5. This indicates a minor update to the page's build/metadata rather than any change to the study content.
    Difference
    0.0%
    Check dated 2026-09-02T19:37:19.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    An additional line, '2017 ( U.S. NIH Grant/Contract )', was added after the EudraCT Number in the study's identifiers. This indicates the U.S. NIH funding source for the project.
    Difference
    0.0%
    Check dated 2026-08-26T19:52:07.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.